Cargando…

CNS demyelinating events in primary Sjögren's syndrome: A single-center case series on the clinical phenotype

OBJECTIVE: The study aimed to assess the prevalence, clinical characteristics, and therapeutic outcomes of the central nervous system (CNS) demyelinating disease in a large cohort of primary Sjögren's syndrome (pSS). METHODS: This is an explorative cross-sectional study of patients with pSS see...

Descripción completa

Detalles Bibliográficos
Autores principales:	Afzali, Ali M., Moog, Philipp, Kalluri, Sudhakar Reddy, Hofauer, Benedikt, Knopf, Andreas, Kirschke, Jan Stefan, Hemmer, Bernhard, Berthele, Achim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978709/ https://www.ncbi.nlm.nih.gov/pubmed/36873454 http://dx.doi.org/10.3389/fneur.2023.1128315

Ejemplares similares

CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
por: Rinaldi, Virginia, et al.
Publicado: (2022)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
por: Ren, Bing-Yan, et al.
Publicado: (2021)

Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients
por: Held, Friederike, et al.
Publicado: (2021)

COVID-19 and the risk of CNS demyelinating diseases: A systematic review
por: Lotan, Itay, et al.
Publicado: (2022)

Para and Post-COVID-19 CNS Acute Demyelinating Disorders in Children: A Case Series on Expanding the Spectrum of Clinical and Radiological Characteristics
por: Khair, Abdulhafeez M, et al.
Publicado: (2022)

Sentinel inflammatory demyelinating lesions preceding primary CNS lymphoma
por: TORRES, Danielle Mesquita, et al.
Publicado: (2021)

Clinical and Prognostic Analysis of Autoantibody-Associated CNS Demyelinating Disorders in Children in Southwest China
por: Li, Ziyan, et al.
Publicado: (2021)

Inhalative Treatment of Laryngitis Sicca in Patients with Sjögren’s Syndrome—A Pilot Study
por: Hofauer, Benedikt, et al.
Publicado: (2022)

Relapsing Demyelinating Syndromes in Children: A Practical Review of Neuroradiological Mimics
por: Chhabda, Sahil, et al.
Publicado: (2020)

Percentage brain volume change in multiple sclerosis mainly reflects white matter and cortical volume
por: Lauerer, Markus, et al.
Publicado: (2022)

Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments
por: Money, Kelli M., et al.
Publicado: (2022)

Systematic evaluation of laryngeal impairment in Sjögren’s syndrome
por: Graf, S., et al.
Publicado: (2021)

Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD
por: Fadda, Giulia, et al.
Publicado: (2022)

CSF Protein Concentration Shows No Correlation With Brain Volume Measures
por: Wuschek, Alexander, et al.
Publicado: (2019)

Not all Sicca is Sjögren's and not all Sjögren's is Sicca
por: Neumann, Melissa, et al.
Publicado: (2021)

Phenotyping variants of tumefactive demyelinating lesions according to clinical and radiological features—A case series
por: Boyle, Thérèse, et al.
Publicado: (2023)

Gray matter atrophy in relapsing-remitting multiple sclerosis is associated with white matter lesions in connecting fibers
por: Bussas, Matthias, et al.
Publicado: (2021)

Chancen und Einsatzmöglichkeiten von Telemedizin in der Hals‑, Nasen- und Ohrenheilkunde bei der Bekämpfung von SARS-COV-2: Narratives Review
por: Hagge, Daniel, et al.
Publicado: (2020)

Recurrent Catatonia and Demyelinating Disorders
por: Jiang, Stephanie M, et al.
Publicado: (2023)

Ocrelizumab-assoziierte schwere Neutropenie: eine unterschätzte Komplikation der Therapie mit CD20-Antikörpern bei Multipler Sklerose?
por: Hess, Felix, et al.
Publicado: (2023)

CNS Demyelination with TNF-α Blockers
por: Kemanetzoglou, Elissavet, et al.
Publicado: (2017)

Isolation, Culture and Functional Characterization of Glia and Endothelial Cells From Adult Pig Brain
por: Tanti, Goutam Kumar, et al.
Publicado: (2019)

Editorial: Epidemiology of Atypical Demyelinating Diseases
por: Rotstein, Dalia, et al.
Publicado: (2021)

Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder—MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders
por: Wagner, Franca, et al.
Publicado: (2018)

Failure of alemtuzumab as a rescue in a NMOSD patient treated with rituximab
por: Kowarik, Markus C., et al.
Publicado: (2016)

The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination
por: Kinzel, Silke, et al.
Publicado: (2017)

Chronic Inflammatory or Chronic Inflammatory Demyelinating Polyradiculoneuropathy?
por: Vallat, Jean-Michel, et al.
Publicado: (2022)

Editorial: Neuropathology of Autoimmune Inflammatory Demyelination Disorders
por: Zeitelhofer, Manuel, et al.
Publicado: (2022)

Editorial: Demyelinating neurological syndromes: The role of autoimmunity
por: Evangelopoulos, Maria Eleftheria, et al.
Publicado: (2023)

Deciphering the Footprints of Autoimmunity in CNS Demyelinating Disorders
por: Netravathi, M
Publicado: (2022)

Peripheral Demyelinating Diseases: From Biology to Translational Medicine
por: Kamil, Khidhir, et al.
Publicado: (2019)

Osmotic Demyelination Syndrome Despite Appropriate Hyponatremia Correction
por: Jahan, Mansura, et al.
Publicado: (2020)

Case Report: Paraneoplastic Tumefactive Demyelination Associated With Seminoma
por: Shiraishi, Wataru, et al.
Publicado: (2022)

Delayed Presentation of Osmotic Demyelination Syndrome Treated With Plasmapheresis
por: Sharif, Muhammad Waqar, et al.
Publicado: (2023)

Prognostic value of white matter lesion shrinking in early multiple sclerosis: An intuitive or naïve notion?
por: Pongratz, Viola, et al.
Publicado: (2019)

Adverse Events in NMOSD Therapy
por: Giglhuber, Katrin, et al.
Publicado: (2022)

Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism
por: Kira, Jun-ichi
Publicado: (2021)

Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS
por: Pavelek, Zbyšek, et al.
Publicado: (2021)

Demyelinating Disease of the Central Nervous System Concurrent With COVID-19
por: Karsidag, Sibel, et al.
Publicado: (2021)

COVID-19-Related Multifocal Demyelinating Neuropathy: Causation or Association
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_na9k6iuie5fi9516s2f3esfcv4